Charles J Yeo Selected Research

Charles J Yeo Research Topics

Disease

126	Neoplasms (Cancer) 12/2023 - 01/2002
113	Adenocarcinoma 06/2023 - 01/2002
85	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 01/2002
17	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2002
17	Pancreatic Fistula (Pancreatic Fistulas) 01/2023 - 11/2004
15	Carcinoma (Carcinomatosis) 03/2024 - 01/2002
10	Neoplasms, Cystic, Mucinous, and Serous 03/2024 - 01/2002
10	Chronic Pancreatitis 01/2018 - 01/2002
7	Pancreatitis 09/2022 - 03/2002
6	Carcinogenesis 01/2022 - 03/2003
6	Wounds and Injuries (Trauma) 12/2021 - 06/2002
5	Inflammation (Inflammations) 04/2015 - 12/2004
4	Diabetes Mellitus 11/2021 - 12/2004
4	Obesity 01/2021 - 02/2009
4	Breast Neoplasms (Breast Cancer) 04/2013 - 01/2003
4	Fistula 01/2013 - 12/2004
3	Acinar Cell Carcinoma 01/2016 - 03/2002
3	Hemorrhage 01/2014 - 02/2003
3	Disease Progression 09/2008 - 12/2004
3	Abscess 11/2006 - 02/2003
3	Adenoma (Adenomas) 01/2005 - 01/2002
3	Pancreatic Diseases (Pancreatic Disease) 01/2003 - 03/2002
2	Duodenal Obstruction 06/2023 - 08/2008
2	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2023 - 01/2018
2	Margins of Excision 03/2021 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2005
2	Esophageal Neoplasms (Esophageal Cancer) 01/2020 - 04/2015
2	Pathologic Constriction (Stenosis) 01/2020 - 05/2006
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020 - 03/2003
2	Tuberculosis (Tuberculoses) 01/2018 - 02/2005
2	Obstructive Jaundice (Cholestatic Jaundice) 01/2018 - 10/2008
2	Pneumonia (Pneumonitis) 01/2017 - 01/2015
2	Insulinoma 01/2017 - 05/2006

Drug/Important Bio-Agent (IBA)

38	Proteins (Proteins, Gene)FDA Link 06/2023 - 03/2002
18	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2002
14	Messenger RNA (mRNA)IBA 01/2022 - 03/2004
11	Gemcitabine FDA Link 01/2018 - 04/2006
9	OsteopontinIBA 04/2015 - 03/2004
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2002
7	EnzymesIBA 01/2021 - 05/2009
6	AntigensIBA 04/2022 - 01/2003
6	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 07/2008
6	MesothelinIBA 03/2015 - 09/2003
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2010 - 07/2003
6	Tumor Biomarkers (Tumor Markers)IBA 09/2004 - 04/2002
5	Protein Isoforms (Isoforms)IBA 04/2022 - 10/2010
5	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 09/2008
5	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 05/2007
5	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2011 - 01/2002
5	Nicotine FDA Link 01/2011 - 07/2009
5	fascinIBA 02/2006 - 07/2002
4	Colloids (Colloid)IBA 03/2024 - 01/2002
4	Phosphotransferases (Kinase)IBA 01/2021 - 10/2003
4	MucinsIBA 04/2012 - 01/2002
4	Angiotensin IIIBA 08/2011 - 05/2007
4	RNA (Ribonucleic Acid)IBA 02/2009 - 05/2002
4	Complementary DNA (cDNA)IBA 11/2004 - 04/2002
3	Amylases FDA Link 06/2018 - 05/2007
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2018 - 05/2003
3	Cadherins (E-Cadherin)IBA 01/2017 - 09/2010
3	AntibodiesIBA 03/2015 - 02/2006
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2014 - 08/2009
3	ParaffinIBA 07/2012 - 05/2002
3	Formaldehyde (Formol)FDA Link 07/2012 - 05/2002
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2011 - 12/2009
3	SmokeIBA 10/2010 - 07/2009
3	Deoxycytidine KinaseIBA 09/2010 - 04/2006
3	OligonucleotidesIBA 04/2004 - 12/2003
3	beta CateninIBA 09/2003 - 03/2002
2	Folic Acid (Vitamin M)FDA LinkGeneric 06/2023 - 08/2005
2	Insulin (Novolin)FDA Link 01/2023 - 09/2004
2	PlatinumIBA 01/2023 - 01/2014
2	AlbuminsIBA 09/2022 - 01/2021
2	Cancer VaccinesIBA 01/2022 - 02/2011
2	Thymidylate SynthaseIBA 01/2021 - 07/2008
2	poly ADP-ribose glycohydrolaseIBA 01/2021 - 01/2019
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 02/2014
2	ElementsIBA 01/2020 - 02/2014
2	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 08/2013
2	thymoquinoneIBA 01/2016 - 08/2009

Therapy/Procedure

49	Pancreaticoduodenectomy 01/2023 - 09/2002
45	Therapeutics 06/2023 - 11/2002
22	Pancreatectomy 12/2023 - 03/2002
17	Drug Therapy (Chemotherapy) 04/2024 - 02/2005
11	Length of Stay 01/2023 - 02/2003
7	Neoadjuvant Therapy 03/2024 - 08/2009
6	Lymph Node Excision (Lymph Node Dissection) 09/2014 - 09/2002
4	Stents 06/2023 - 05/2005
4	Esophagectomy 01/2020 - 02/2003
4	Operative Time 01/2020 - 12/2004
3	Cholecystectomy 01/2020 - 09/2002
3	Radiotherapy 01/2019 - 10/2005
3	Splenectomy 01/2018 - 08/2013
3	Laparotomy 01/2016 - 01/2002
3	Laparoscopic Cholecystectomy 06/2007 - 06/2002
3	Gastrectomy 12/2005 - 09/2002
2	Patient Readmission 04/2024 - 01/2014
2	Immunotherapy 01/2022 - 02/2011
2	Adjuvant Chemotherapy 11/2021 - 01/2018
2	Pancreaticojejunostomy 01/2017 - 05/2009